Euclidean Capital’s Denali Therapeutics DNLI Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-323,749	Closed	-$25.4M	–	12
2021 Q2	$25.4M	Hold	323,749	–	–	8.24%	3
2021 Q1	$18.5M	Hold	323,749	–	–	6.19%	5
2020 Q4	$27.1M	Buy	+323,749	New	+$27.1M	5.74%	4